To Establish Whether Individuals With Premenstrual Dysphoric Disorder (PMDD) Demonstrate a Different Luteal-phase Sex Hormone Profile and Ratio Compared With Asymptomatic Controls.
NCT07686718 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2026-07-07
Summary
The aim of this project is to compare the ovarian hormone levels 7 days after ovulation and progesterone:oestradiol ratios between PMDD individuals and a control cohort (case control study).
Conditions
- Premenstrual Dysphoric Disorder ( PMDD)
Sponsors & Collaborators
-
Lancaster University
lead OTHER
Principal Investigators
-
Chris Gaffney, BSc (Hons.) MSc PhD SFHEA · Lancaster University
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-05-05
- Primary Completion
- 2027-08-01
- Completion
- 2027-08-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling
NCT05212389 ·Status: UNKNOWN ·Phase: NA
-
The Oral Contraceptive Pill for Premenstrual Worsening of Depression
NCT00633360 ·Status: COMPLETED ·Phase: NA
-
Oral Contraceptive Therapy and Sexuality
NCT02613039 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Oestrogen on Musculoskeletal Outcomes
NCT05587920 ·Status: UNKNOWN
-
A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives
NCT01291004 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
NCT00089414 ·Status: TERMINATED ·Phase: PHASE2
-
The Effect of Progesterone on Human Endometrium
NCT04323683 ·Status: COMPLETED
-
Investigating the Endocrine-metabolic-immunological Axis During the Female Menstrual Cycle by Functional Genomics
NCT06072391 ·Status: RECRUITING
-
Study of Safety and Efficacy of an Oral Contraceptive
NCT00391807 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of the Menstrual Cycle and Oral Contraceptive Use on Health and Performance in Athletes
NCT07591818 ·Status: RECRUITING
-
The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology
NCT05683119 ·Status: RECRUITING ·Phase: NA
-
Performance During Menstrual Cycle
NCT03832972 ·Status: COMPLETED
-
Medical Treatment of Endometriosis-Associated Pelvic Pain
NCT00229996 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Hormonal Contraception on Female
NCT01852786 ·Status: UNKNOWN
-
Investigation of Female Reproductive Hormone Dynamics During Adolescence
NCT02486757 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Hormonal Imbalance
NCT05328609 ·Status: COMPLETED ·Phase: NA
-
Cycle Control Assessment of a Combined Oral Contraceptive Containing Estetrol and a Progestin P1 or P2
NCT01221831 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of the Female Hormones on Cerebral Perfusion
NCT03299179 ·Status: RECRUITING
-
Oral Contraceptives and Economic Behaviour
NCT02257671 ·Status: UNKNOWN ·Phase: NA
-
YAZ Premenstrual Dysphoric Disorder (PMDD) in China
NCT00824187 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Contraceptive vs Menstrual Cycle Ex Vivo Model
NCT06124274 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea
NCT00746096 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Contraceptive Consumption Timing and Cognition and Metabolism
NCT06560944 ·Status: COMPLETED ·Phase: NA
-
Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)
NCT01650168 ·Status: COMPLETED
-
Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control
NCT01250210 ·Status: COMPLETED ·Phase: PHASE2